Genetics may influence the body’s response to low oxygen, study finds

Genetics may influence the body’s response to low oxygen, study finds
Immunofluorescent staining for the lncRNA fragment in a diseased pulmonary vessel from a patient with pulmonary arterial hypertension. Credit: Thomas Bertero

University of Pittsburgh Schools of Medicine researchers uncovered a fundamental mechanism that controls the body’s response to limited oxygen and regulates blood vessel disease of the lung.

By combing through genomes of more than 20,000 individuals in the U.S., France, England and Japan and combining the results with in the lab, the team discovered a shared genetic trait that could predict a higher risk of small lung vessel disease called and its more severe form, , and influence the development of drug therapies that target the body’s response to limited oxygen. The findings were published in Science Translational Medicine.

“This new level of knowledge will help identify people who may be at a higher genetic risk of pulmonary and jump-start precision medicine practices to offer customized treatments,” said senior author Stephen Chan, M.D., Ph.D., a cardiologist who serves as the Vitalant Chair in Vascular Medicine and director of the Vascular Medicine Institute at Pitt.

Pulmonary hypertension encompasses a range of conditions of various causes that manifest in in the arteries of the lung and the right side of the heart. The disease is accompanied by a decreased supply of oxygen to the and the blood, is chronic and deadly, and its molecular origins and genetic background remain unsolved.

Chan lab at the University of Pittsburgh. Credit: Johnathan Wright

Using a combined approach of genomics and biochemistry, the Chan lab found a gene pair that had an important function in regulating blood vessel metabolism and disease. This gene pair included a long non-coding RNA molecule—a messenger that facilitates the transformation of the body’s into protein products—and a protein binding partner, and their interaction was frequently active in cells exposed to low oxygen compared to normal cells.

Taking the findings a step further, the team discovered that a single DNA letter change directing expression of this RNA-protein pair under low oxygen conditions was associated with a higher genetic risk of pulmonary hypertension across diverse patient populations.

According to Chan, pulmonary hypertension is a borderline orphan disease, and the limited number of patients with pulmonary hypertension makes it challenging to find genetic variations that are rare but still impactful enough to eclipse .

With that in mind, Pitt scientists turned to collaborators around the globe and to public research datasets such as All of Us—a nationwide health registry—to ensure that the findings are relevant across a diverse global population.

Chan hopes that his findings will spur the development of targeted therapies relevant to oxygen sensitivity in blood vessel lining and that their pending patent application will contribute to the growth of an entirely new field of epigenetic and RNA drug therapeutics that work not by manipulating the genome but by changing how it is being read.

More information:
Yi Yin Tai et al, Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension, Science Translational Medicine (2024). DOI: 10.1126/scitranslmed.add2029. www.science.org/doi/10.1126/scitranslmed.add2029

Citation:
Genetics may influence the body’s response to low oxygen, study finds (2024, January 10)
retrieved 10 January 2024
from https://medicalxpress.com/news/2024-01-genetics-body-response-oxygen.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Read More

Zaļā Josta - Reklāma